Kendal K. Whitlock is the Head of Digital Optimization, RWE Clinical Trials, with Walgreens Boots Alliance. This role leverages data assets and partnerships to advance culturally responsive approaches to clinical research. In her role, Ms. Whitlock focuses on digital solutions to drive access and opportunities that are both flexible and convenient for participants.
Ms. Whitlock brings nearly 25 years of pharmaceutical industry experience to this new role. During her tenure, she has worked globally in digital clinical trials, and in both medical and commercial roles.
Ms. Whitlock holds a Master of Public Health degree in Sociomedical Sciences from Columbia University and is currently working toward a doctorate. She earned a BA with honors from Spelman College.
Ms. Whitlock has published in peer-reviewed journals, speaks internationally, is a Co-Lead of the 3C Decentralized Clinical Trials (DCT) Research Curriculum Initiative for the Decentralized Trials Research Alliance (DTRA), Chair of the Product Development and Clinical Research Sub-committee for the Med Tech Color Collaborative Community, and a member of the Personalized Medicine Coalition (PMC) Health Equity Task Force.